Abstract
Among patients with psoriasis who did not achieve Psoriasis Area and Severity Index 50 during the first course of alefacept therapy, 53% achieved Psoriasis Area and Severity Index 50 during the second course (odds ratio [95% confidence interval] vs placebo 2.30 [1.26-4.19]). Alefacept provided incremental efficacy over 5 successive 12-week treatment courses.
Original language | English |
---|---|
Pages (from-to) | 61-63 |
Number of pages | 3 |
Journal | Journal of the American Academy of Dermatology |
Volume | 54 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2006 |